본문 바로가기
KERD
논문KCI 등재

Proteomics in Rheumatoid Arthritis Research

정민경|김완욱|황대희|박윤정
대한면역학회 (The Korean Association of Immunologists)|2015.08|Immune Network|제15권 제4호|pp. 177-185|DOI http://dx.doi.org/10.4110/in.2015.15.4.177

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Rheumatoid arthritisBiomarkerProteomics

초록

Although rheumatoid arthritis (RA) is the most common chronic inflammatory autoimmune disease, diagnosis of RA is currently based on clinical manifestations, and there is no simple, practical assessment tool in the clinical field to assess disease activity and severity. Recently, there has been increasing interest in the discovery of new diagnostic RA biomarkers that can assist in evaluating disease activity, severity, and treatment response. Proteomics, the largescale study of the proteome, has emerged as a powerful technique for protein identification and characterization. For the past 10 years, proteomic techniques have been applied to different biological samples (synovial tissue/fluid, blood, and urine) from RA patients and experimental animal models. In this review, we summarize the current state of the application of proteomics in RA and its importance in identifying biomarkers and treatment targets.

Abstract

Although rheumatoid arthritis (RA) is the most common chronic inflammatory autoimmune disease, diagnosis of RA is currently based on clinical manifestations, and there is no simple, practical assessment tool in the clinical field to assess disease activity and severity. Recently, there has been increasing interest in the discovery of new diagnostic RA biomarkers that can assist in evaluating disease activity, severity, and treatment response. Proteomics, the largescale study of the proteome, has emerged as a powerful technique for protein identification and characterization. For the past 10 years, proteomic techniques have been applied to different biological samples (synovial tissue/fluid, blood, and urine) from RA patients and experimental animal models. In this review, we summarize the current state of the application of proteomics in RA and its importance in identifying biomarkers and treatment targets.

참고문헌 (60)

  1. Smolen, J. S., "Patients with rheumatoid arthritis in clinical care", Ann. Rheum. Dis, 63, pp.221~225 (2004)
  2. Wolfe, F., "Predicting mortality in patients with rheumatoid arthritis", Arthritis Rheum, 48, pp.1530~1542 (2003)
  3. Pincus, T., "Severe functional declines, work disability, increased mortality in seventy-five rheumatoid arthritis patients studied over nine years", Arthritis Rheum, 27, pp.864~872 (1984)
  4. Sokka, T., "Healing of erosions in rheumatoid arthritis", Ann. Rheum. Dis, 59, pp.647~649 (2000)
  5. Rau, R., "Identification of radiologic healing phenomena in patients with rheumatoid arthritis", J. Rheumatol, 28, pp.2608~2615 (2001)
  6. van der, H. D., "Imaging: do erosions heal?", Ann. Rheum. Dis, 62(Suppl 2), pp.ii10~ii12 (2003)
  7. Ideguchi, H., "Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs", Arthritis Res. Ther, 8, pp.R76~ (2006)
  8. Arnett, F. C., "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis", Arthritis Rheum, 31, pp.315~324 (1988)
  9. Aletaha, D., "2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2010, pp.62, 2569~2581
  10. Aletaha, D., "2010 rheumatoid arthritis classification criteria: an American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2010, pp.69, 1580~1588
  11. Harrison, B. J., "The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association", J. Rheumatol, 25, pp.2324~2330 (1998)
  12. Machold, K. P., "Very recent onset arthritis--clinical, laboratory, radiological findings during the first year of disease", J. Rheumatol, 29, pp.2278~2287 (2002)
  13. Boers, M., "Randomised comparison of combined step-down prednisolone, methotrexate sulphasalazine with sulphasalazine alone in early rheumatoid arthritis", Lancet, 350, pp.309~318 (1997)
  14. Goekoop-Ruiterman, Y. P., "Clinical radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial", Arthritis Rheum, 52, pp.3381~3390 (2005)
  15. Pincus, T., "Evidence from clinical trials long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review", Rheumatology, 41, pp.1346~1356 (2002)
  16. Aletaha, D., "The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses", Rheumatology, 41, pp.1367~1374 (2002)
  17. Combe, B., "EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)", Ann. Rheum. Dis, 66, pp.34~45 (2007)
  18. Emery, P., "Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide", Ann. Rheum. Dis, 61, pp.290~297 (2002)
  19. Prevoo, M. L., "Modified disease activity scores that include twenty-eight-joint counts. Development validation in a prospective longitudinal study of patients with rheumatoid arthritis", Arthritis Rheum, 38, pp.44~48 (1995)
  20. van der Heijde, D., "How to read radiographs according to the Sharp", van der Heijde method, 2000, pp.27, 261~263
  21. Wilkins, M. R., "From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis amino acid analysis", Biotechnology, 14, pp.61~65 (1996)
  22. Anderson, N. L., "Proteome proteomics:new technologies, new concepts, new words", Electrophoresis, 19, pp.1853~1861 (1998)
  23. Blackstock, W. P., "Proteomics: quantitative physical mapping of cellular proteins", Trends Biotechnol, 17, pp.121~127 (1999)
  24. Mallick, P., "Proteomics: a pragmatic perspective", Nat. Biotechnol, 28, pp.695~709 (2010)
  25. Ryu, S. Y., "Bioinformatics tools to identify quantify proteins using mass spectrometry data", Adv. Protein Chem. Struct. Biol, 94, pp.1~17 (2014)
  26. Aebersold, R., "Mass spectrometry-based proteomics", Nature, 422, pp.198~207 (2003)
  27. Kim, S. J., "A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus", Mol. Cell. Proteomics, 13, pp.811~822 (2014)
  28. Wilhelm, M., "Mass-spectrometry-based draft of the human proteome", Nature, 509, pp.582~587 (2014)
  29. Farrah, T., "A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas", Mol. Cell. Proteomics, 10 (2011)
  30. Rigaut, G., "A generic protein purification method for protein complex characterization proteome exploration", Nat. Biotechnol, 17, pp.1030~1032 (1999)
  31. Venne, A. S., "The next level of complexity: crosstalk of posttranslational modifications", Proteomics, 14, pp.513~524 (2014)
  32. Boja, E. S., "Mass spectrometry-based targeted quantitative proteomics: achieving sensitive reproducible detection of proteins", Proteomics, 12, pp.1093~1110 (2012)
  33. Angel, T. E., "Mass spectrometry-based proteomics: existing capabilities future directions", Chem. Soc. Rev, 41, pp.3912~3928 (2012)
  34. Johnson, H., "Analysis of post-translational modifications by LC-MS", MS, 2010, pp.658, 93~108
  35. Konermann, L., "Hydrogen exchange mass spectrometry for studying protein structure dynamics", Chem. Soc. Rev, 40, pp.1224~1234 (2011)
  36. Zhang, Z., "Mass spectrometry for structural characterization of therapeutic antibodies", Mass Spectrom. Rev, 28, pp.147~176 (2009)
  37. Tilleman, K., "Proteomics in rheumatology", Expert Rev. Proteomics, 5, pp.755~759 (2008)
  38. Dasuri, K., "The synovial proteome:analysis of fibroblast-like synoviocytes", Arthritis Res. Ther, 6, pp.R161~R168 (2004)
  39. Li, X. J., "Proteomic analysis of synovial fibroblast-like synoviocytes from rheumatoid arthritis", Clin. Exp. Rheumatol, 31, pp.552~558 (2013)
  40. Yoo, S. A., "A novel pathogenic role of the ER chaperone GRP78", BiP in rheumatoid arthritis, 2012, pp.209, 871~886
  41. Van Riel PL, "Rheumatology", pp.11~13 (1998), Mosby
  42. Kang, M. J., "Urinary proteome profile predictive of disease activity in rheumatoid arthritis", J. Proteome. Res, 13, pp.5206~5217 (2014)
  43. Liao, H., "Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid serum of patients with rheumatoid arthritis", Arthritis Rheum, 50, pp.3792~3803 (2004)
  44. Haraoui, B., "Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire", Ann. Rheum. Dis, 70, pp.1999~2002 (2011)
  45. Smolen, J. S., "EULAR recommendations for the management of rheumatoid arthritis with synthetic biological disease-modifying antirheumatic drugs: 2013 update", Ann. Rheum. Dis, 73, pp.492~509 (2014)
  46. Mewar, D., "Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors", Br. J. Pharmacol, 162, pp.785~791 (2011)
  47. Sekigawa, I., "Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy", Clin. Exp. Rheumatol, 26, pp.261~267 (2008)
  48. Sellam, J., "Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial", Arthritis Rheumatol, 66, pp.2015~2025 (2014)
  49. Zheng, X., "Study of the human plasma proteome of rheumatoid arthritis", J. Chromatogr. A, 1216, pp.3538~3545 (2009)
  50. 진은희, "Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders", Experimental and Molecular Medicine, 41(5), pp.354~361 (2009), 생화학분자생물학회
  51. Kastrinaki, M. C., "Functional, molecular proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis", Ann. Rheum. Dis, 67, pp.741~749 (2008)
  52. Bo, G. P., "Analyses of differential proteome of human synovial fibroblasts obtained from arthritis", Clin. Rheumatol, 28, pp.191~199 (2009)
  53. Zhang, H., "Proteins related to the functions of fibroblast-like synoviocytes identified by proteomic analysis", Clin. Exp. Rheumatol, 30, pp.213~221 (2012)
  54. Katano, M., "Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis", Arthritis Res. Ther, 11, pp.R3~ (2009)
  55. Dotzlaw, H., "A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys", Acta, 1696, pp.121~129 (2004)
  56. Schulz, M., "Proteomic analysis of peripheral blood mononuclear cells:selective protein processing observed in patients with rheumatoid arthritis", J. Proteome Res, 6, pp.3752~3759 (2007)
  57. Lu, M. C., "Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte", macrophages stimulate tumor necrosis factor alpha production, 2010, pp.62, 1213~1223
  58. Tilleman, K., "Chronically inflamed synovium from spondyloarthropathy rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry", Proteomics, 5, pp.2247~2257 (2005)
  59. Watanabe, J., "Proteomic profiling following immunoaffinity capture of high-density lipoprotein:association of acute-phase proteins complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis", Arthritis Rheum, 64, pp.1828~1837 (2012)
  60. Giusti, L., "Is GRP78", BiP a potential salivary biomarker in patients with rheumatoid arthritis?, 2010, pp.4, 315~324

관련 논문AI추천

류마티스 관절염 진단을 위한 검사의 유용성 비교박창은대한임상검사과학회 · 대한임상검사과학회지2015 · 제47권 제4호Recent Paradigm Shifts in the Diagnosis and Treatment of Rheumatoid Arthritis김현아, 정영옥대한내과학회 · The Korean Journal of Internal Medicine2012 · 제27권 제4호Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research김민교, 이상일, 채용호대한면역학회 · Immune Network2022 · 제22권 제1호Synovial Fluid as a Crucial Component of the Joint Microenvironment in Rheumatoid ArthritisAripova Tamara Uktamovna, Bjørklund Geir, Chirumbolo Salvatore, Gaffarov Usmon Bobonazarovich, Kamalov Zaynitdin Saifitdinovich, Khamidov Obid Abdurakhmanovich, Khudaiberdiev Shavkat Shukhratovich, Rizaev Jasur Alimdjanovich, Tashkenbaeva Eleonora Negmatovna, Ziyadullaev Shukhrat Khudaiberdievich대한면역학회 · Immune Network2025 · 제25권 제2호Lipidome profile predictive of disease evolution and activity in rheumatoid arthritis고정희, 권성원, 김현숙, 임요한, Cho Seonghun, Kim Mina, Kim Wan-Uk, Park Youngjae, Yoon Sang Jun생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 The use of animal models in rheumatoid arthritis research유승아, Gi Heon Jeong, Jin-Sun Kong영남대학교 의과대학 · Journal of Yeungnam Medical Science2023 · 제40권 제1호

이 간행물의 다른 논문 (5건)

New Insights Into Tissue Macrophages: From Their Origin to the Development of MemoryPaola Italiani, Diana Boraschipp. 167-176Cytomegalovirus Infection and Memory T Cell Inflation김지혜, 신의철, 김아름pp. 186-190Immune-mediated Liver Injury in Hepatitis B Virus Infection오인수, 박수형pp. 191-198Anti-proliferative Activity of T-bet신지현, 원희연, 황은숙, 오연지pp. 199-205Involvement of Protein Kinase C-δ in Vascular Permeability in Acute Lung Injury이민현, 권병석, 박순은, 안종준, 정종필, 조홍래pp. 206-211
원문 보기